Effects of diet enriched with indigestible complex starch on chronic hemodialysis patients.
Phase 2
- Conditions
- Chronic kidney disease, stage 5.Chronic kidney disease, stage 5
- Registration Number
- IRCT2016062628644N1
- Lead Sponsor
- Vice Chancellor for research of Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Chronic kidney disease patients who are on chronic hemodialysis for more than 6 months.
Exclusion criteria: Diabetic patients; Patients who have active infection; Patients who have inflammatory diseases; Patients who are under 18 years old.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method High-density lipoprotein (HDL). Timepoint: 8 weeks following end of treatment. Method of measurement: Sampling from blood, urine and fecal of patients.;Interleukin (IL)-1b. Timepoint: 8 weeks following end of treatment. Method of measurement: Sampling from blood, urine and fecal of patients.;Interleukin (IL)-6. Timepoint: 8 weeks following end of treatment. Method of measurement: Sampling from blood, urine and fecal of patients.
- Secondary Outcome Measures
Name Time Method -. Timepoint: -. Method of measurement: -.